|

Aromatase Inhibitors or Fulvestrant Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Fudan University1

Indications

  • Hormone Receptor Positive Tumor1
  • HER2-negative Breast Cancer1
  • Advanced Breast Cancer1
  • Breast Neoplasm1
  • Breast Cancer1

Other1 trial

SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.